Table 1.
Validation of AlphaScreen Allele-Specific Amplification
| SNP marker | Alternative genotyping method | Number of samples tested | Correct genotypes |
| NCBI assay Id 4621 | Sequencing | 20 | 20 |
| NCBI assay Id 4568 | Sequencing | 20 | 20 |
| NCBI assay Id 394 | Sequencing | 17 | 17 |
| NCBI assay Id 5173 | Sequencing | 20 | 20 |
| NCBI assay Id 336 | Sequencing | 20 | 20 |
| CDC45L | Single-strand conformation polymorphism | 22 | 22 |
| TBX1 | Single-strand conformation polymorphism | 21 | 20 |
| WIAF-3710 | 5′-nuclease assay (TaqMan probes) | 41 | 41 |
| WIAF-395 | 5′-nuclease assay (TaqMan probes) | 44 | 44 |
| WIAF-985 | 5′-nuclease assay (TaqMan probes) | 45 | 45 |
| WIAF-896 | 5′-nuclease assay (TaqMan probes) | 44 | 42 |
| WIAF-332 | 5′-nuclease assay (TaqMan probes) | 44 | 44 |
| Total | 358 | 355 (99.2%) |
